https://scholars.lib.ntu.edu.tw/handle/123456789/469991
Title: | Risk-directed therapy and research in neuroblastoma | Authors: | Liu Y.-L. Miser J.S. WEN-MING HSU |
Issue Date: | 2014 | Publisher: | Elsevier | Journal Volume: | 113 | Journal Issue: | 12 | Start page/Pages: | 887-889 | Source: | Journal of the Formosan Medical Association | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84918515454&doi=10.1016%2fj.jfma.2014.11.001&partnerID=40&md5=52452c0571c35fb411c8db16d5715569 https://scholars.lib.ntu.edu.tw/handle/123456789/469991 |
ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2014.11.001 | SDG/Keyword: | isotretinoin; MYCN protein, human; nuclear protein; oncoprotein; autologous stem cell transplantation; cancer radiotherapy; disease course; follow up; high risk population; human; induction chemotherapy; nerve cell differentiation; neuroblastoma; palliative therapy; Short Survey; Taiwan; adolescent; cancer staging; child; gene amplification; gene dosage; genetics; infant; medical research; neuroblastoma; newborn; pathology; preschool child; prognosis; risk assessment; young adult; Adolescent; Biomedical Research; Child; Child, Preschool; Gene Amplification; Gene Dosage; Humans; Infant; Infant, Newborn; Neoplasm Staging; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Prognosis; Risk Assessment; Young Adult |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.